Savchuk Nikolay
SEC insider (Form 3/4/5 filer). CIK 0002017800. Chief Operating Officer at Traws Pharma, Inc. (TRAW) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in NEWTOWN, PA.
Companies Savchuk Nikolay has filed insider reports for
- Traws Pharma, Inc. (TRAW): Director, Officer, Chief Operating Officer
- Lomond Therapeutics Holdings, Inc. (NONE): Director, Officer, President and COO
Savchuk Nikolay
CIK: 0002017800
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jul 9, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
93K shares- - Mar 8, 2026TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to buy)
96.9K shares- - Dec 12, 2025TRAW
Traws Pharma, Inc.
AwardDirect16.4K shares- - Oct 12, 2025TRAW
Traws Pharma, Inc.
AwardDirectStock Option (right to purchase)
22.4K shares- - Dec 29, 2024TRAW
Traws Pharma, Inc.
PurchaseIndirectPre-Funded Warrant (right to buy)
96.3K shares- - Dec 29, 2024TRAW
Traws Pharma, Inc.
PurchaseIndirectSeries A Warrant (right to buy)
96.3K shares- - Nov 1, 2024No ticker
Lomond Therapeutics Holdings, Inc.
AwardIndirect1.4M shares at avg. $4.00$5.8M - Nov 1, 2024No ticker
Lomond Therapeutics Holdings, Inc.
ConversionIndirect694.4K shares at avg. $3.60$2.5M - Nov 1, 2024No ticker
Lomond Therapeutics Holdings, Inc.
ConversionIndirect539.1K shares at avg. $3.20$1.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 9, 2026 |  TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 93,000 | - | - | Direct |
| Mar 8, 2026 | TRAW Traws Pharma, Inc. | Award Stock Option (right to buy) | 96,899 | - | - | Direct |
| Dec 12, 2025 | TRAW Traws Pharma, Inc. | Award | 16,419 | - | - | Direct |
| Oct 12, 2025 | TRAW Traws Pharma, Inc. | Award Stock Option (right to purchase) | 22,435 | - | - | Direct |
| Dec 29, 2024 | TRAW Traws Pharma, Inc. | Purchase Pre-Funded Warrant (right to buy) | 96,348 | - | - | Indirect |
| Dec 29, 2024 | TRAW Traws Pharma, Inc. | Purchase Series A Warrant (right to buy) | 96,348 | - | - | Indirect |
| Nov 1, 2024 |  No ticker Lomond Therapeutics Holdings, Inc. | Award | 1,443,750 | $4.00 | $5,775,000 | Indirect |
| Nov 1, 2024 | No ticker Lomond Therapeutics Holdings, Inc. | Conversion | 694,444 | $3.60 | $2,499,998 | Indirect |
| Nov 1, 2024 | No ticker Lomond Therapeutics Holdings, Inc. | Conversion | 539,062 | $3.20 | $1,724,998 | Indirect |
1-9 of 9 transactions